Rheumatoid Arthritis Posts Page 2 on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Is hydroxychloroquine an effective treatment for rheumatoid arthritis?

Posted by on Mar 22, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if hydroxychloroquine (HCQ; Plaquenil) is an effective treatment in rheumatoid arthritis (RA). They found that combining HCQ with other RA drugs improves symptoms. Some background Rheumatoid arthritis (RA) is a long-term condition. It is caused by excessive inflammation in the joints. This leads to painful...

Read More

Early intervention and mortality risk – are there benefits for patients with rheumatoid arthritis?

Posted by on Mar 16, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the mortality rates in patients with early rheumatoid arthritis (RA). They found that mortality rates were similar to the general population in these patients. Some background Rheumatoid arthritis (RA) is a long-term condition. It causes painful inflammation in the joints. To treat RA, patients take...

Read More

Fatigue in rheumatoid arthritis: can behavioral therapy improve symptoms?

Posted by on Mar 5, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if behavioral therapy improves fatigue in rheumatoid arthritis (RA). They found that behavioral therapy reduced fatigue in patients with RA. Some background Rheumatoid arthritis (RA) is a long-term condition caused by inflammation. It leads to painful swelling in the joints and disability. Fatigue (tiredness)...

Read More

Tofacitinib alone or in combination to treat rheumatoid arthritis: a safety update from clinical trials

Posted by on Feb 28, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety of tofacitinib (TFB; Xeljanz) in the treatment of rheumatoid arthritis (RA). They found that patients taking TFB alone had a reduced risk of infections. Some background Rheumatoid arthritis (RA) is a chronic condition caused by inflammation. This leads to painful swelling in the joints and...

Read More

Looking for patients with rheumatoid arthritis to trial a new stem cells treatment

Posted by on Feb 27, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This phase 1/2a trial will investigate the safety of an autologous mesenchymal stem cell transplant (AMSCT) to treat rheumatoid arthritis (RA). The main outcome measured will be the safety of AMSCT and response after 1 year. This trial is recruiting in Texas, United States. The details Rheumatoid arthritis (RA) is a chronic...

Read More

Exercise in juvenile idiopathic arthritis: can an 8-week program improve exercise capacity?

Posted by on Feb 26, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if water-based exercise (WBE) improved exercise capacities (ECs) in juvenile idiopathic arthritis (JIA).  They found that anaerobic exercise capacity (AnEC) was improved in patients with JIA.  Some background Juvenile idiopathic arthritis (JIA) is a condition that affects children under the age of...

Read More

Predicting treatment success in early RA: can biomarkers predict methotrexate response?

Posted by on Feb 26, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if biomarkers (BMs) can predict the response to methotrexate (MTX) in early rheumatoid arthritis (RA). They found that the level of BMs at baseline could predict the success of MTX treatment. Some background Rheumatoid arthritis (RA) is a condition caused by inflammation. This leads to painful swelling...

Read More

Reducing cardiovascular disease risk in rheumatoid arthritis: is treat-to-target the best approach?

Posted by on Feb 26, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if a treat-to-target (TTT) approach reduces cardiovascular disease (CVD) risk in patients with rheumatoid arthritis (RA). They found that TTT reduced CVD risk in patients with RA over 5 years.  Some background Rheumatoid arthritis (RA) is a chronic condition caused by inflammation. Patients with RA have...

Read More

Seasonal effects in rheumatoid arthritis: when is disease activity lowest?

Posted by on Jan 31, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated disease activity in patients with rheumatoid arthritis (RA) by season. They found that disease activity was lowest in fall and highest in spring. Some background Rheumatoid arthritis (RA) is a condition affecting the joints of the body. In RA, there is an excess of inflammation. This leads to painful swelling...

Read More

Looking for patients with rheumatoid arthritis to test a new drug

Posted by on Jan 27, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This phase 1b/2a trial will investigate the safety and effectiveness of AMG 592 in rheumatoid arthritis (RA). The main outcome will be a 20% improvement in symptoms at week 12.  The details Rheumatoid arthritis (RA) is a condition caused by long-term inflammation. This leads to painful swelling in the joints. To treat RA, drugs that...

Read More

Is vitamin D deficiency linked to disease activity in juvenile idiopathic arthritis?

Posted by on Jan 20, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if vitamin D levels and disease activity are linked in juvenile idiopathic arthritis (JIA). They found that low vitamin D levels were associated with higher disease activity. Some background Juvenile idiopathic arthritis (JIA) is caused by inflammation in the joints. The cause of JIA is unknown. In JIA, the...

Read More